The vision of the Centre of Molecular Inflammation Research (CEMIR) is to lay the foundation for identifying new therapeutic targets and developing new diagnostic tools for inflammatory diseases. 

Inflammation is a host response that is triggered by infection and tissue injury. A controlled inflammatory response is needed to fight infections and to heal wounds, but it can become detrimental if it is dysregulated as seen in chronic inflammatory disorders like cardiovascular disease, diabetes, Alzheimer's disease, inflammatory bowel disease, obesity, cancer, and inflammatory pregnancy disorders like preeclampsia.

Drawing on major recent advances in the field of innate immunity and cell biology, CEMIR's research programme details the molecular and cell biological principles for initiation and regulation of inflammatory responses through the use of basic research, in vitro- and in vivo models and translational unique patient based biobanks. The localization of CEMIR in an integrated University hospital environment facilitates translational research on human disease.